Review: The blood-brain barrier; protecting the developing fetal brain

Placenta

Volumn 54, Issue , 2017, Pages 111-116

  Goasdoué, Kate ^a   Miller, Stephanie M ^a   Colditz, Paul B ^a   Björkman, S Tracey ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Blood brain barrier; Drug transporters; Fetal brain development; P glycoprotein

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; GLYCOPROTEIN; ILLICIT DRUG; MULTIDRUG RESISTANCE PROTEIN; NANOPARTICLE; SEROTONIN UPTAKE INHIBITOR; SOLUTE CARRIER PROTEIN; TIGHT JUNCTION PROTEIN; TRYPAN BLUE;

ACTIVE TRANSPORT; ASTROCYTE; BASOLATERAL MEMBRANE; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; DRUG TRANSPORT; EFFLUX TRANSPORT; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; FETUS; FETUS BRAIN; HUMAN; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULARIZATION; ANIMAL; FEMALE; FETUS DEVELOPMENT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PLACENTA; PREGNANCY;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; FEMALE; FETAL DEVELOPMENT; HUMANS; PLACENTA; PREGNANCY; SOLUTE CARRIER PROTEINS;

EID: 85007579364     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2016.12.005     Document Type: Review

References (74)

1. Sandovici, I., Hoelle, K., Angiolini, E., Constância, M., Placental adaptations to the maternal-fetal environment: implications for fetal growth and developmental programming. Reprod. Biomed. Online 25 (2012), 68–89.
2. Griffiths, S., Campbell, J.P., Placental structure, function and drug transfer. Contin. Educ. Anaesth. Crit. Care Pain 15 (2014), 84–89.
3. Brown, C.H., Grattan, D.R., Does maternal oxytocin protect the fetal brain?. Trends Endocrinol. Metab. 18 (2007), 225–226.
4. Barcroft, J., Kennedy, J.A., The distribution of blood between the foetus and the placenta in sheep. J. Physiol. 95 (1938), 173–186.
5. Saunders, N.R., Dreifuss, J.J., Dziegielewska, K.M., Johansson, P.A., Habgood, M.D., Mollgard, K., et al. The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history. Front. Neurosci., 8, 2014, 404.
6. Daneman, R., Prat, A., The blood-brain barrier. Cold Spring Harb. Perspect. Biol., 7, 2015, a020412.
7. Weed, L., The development of the cerebrospinal fluid spaces in pig and in man. Contrib. Embryol. Carnegie Inst. 5 (1917), 3–116.
8. Cohen, H., Davies, S., The morphology and permeability of the roof of the fourth ventricle in some mammalian embryos. J. Anat. 72 (1938), 430–455.
9. Grazer, F.M., Clemente, C.D., Developing blood brain barrier to trypan blue. Proc. Soc. Exp. Biol. Med. 94 (1957), 758–760.
10. Grontoft, O., Intracranial haemorrhage and blood-brain barrier problems in the new-born; a pathologico-anatomical and experimental investigation. Acta Pathol Microbiol Sc Suppl. 100 (1954), 8–109.
11. Ek, C.J., Dziegielewska, K.M., Habgood, M.D., Saunders, N.R., Barriers in the developing brain and Neurotoxicology. Neurotoxicology 33 (2012), 586–604.
12. Møllgård, K., Saunders, N.R., Complex tight junctions of epithelial and of endothelial cells in early foetal brain. J. Neurocytol. 4 (1975), 453–468.
13. Stewart, P.A., Hayakawa, K., Early ultrastructural changes in blood-brain barrier vessels of the rat embryo. Brain Res. Dev. Brain Res. 78 (1994), 25–34.
14. Zhao, Z., Nelson, A.R., Betsholtz, C., Zlokovic, B.V., Establishment and dysfunction of the blood-brain barrier. Cell 163 (2015), 1064–1078.
15. Virgintino, D., Robertson, D., Benagiano, V., Errede, M., Bertossi, M., Ambrosi, G., et al. Immunogold cytochemistry of the blood-brain barrier glucose transporter GLUT1 and endogenous albumin in the developing human brain. Dev. Brain Res. 123 (2000), 95–101.
16. Virgintino, D., Errede, M., Robertson, D., Capobianco, C., Girolamo, F., Vimercati, A., et al. Immunolocalization of tight junction protein in the adult and developing human brain. Histochem. Cell Biol. 122 (2004), 51–59.
17. Kniesel, U., Risau, W., Wolburg, H., Development of blood-brain barrier tight junctions in the rat cortex. Dev. Brain Res. 96 (1996), 229–240.
18. Guerra, A., King, J.M., Alajajian, B., Isgor, E., Digicaylioglu, M., Occludin and Claudin-5 are comparably abundant and Co-Localized in the rats; blood brain barrier from late gestation to adulthood. e-Journal Neonatol. Res. 1 (2011), 31–43.
19. Hayashi, Y., Nomura, M., Yamagishi, S., Harada, S., Yamashita, J., Yamamoto, H., Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia 19 (1997), 13–26.
20. Lee, S.W., Kim, W.J., Choi, Y.K., Song, H.S., Son, M.J., Gelman, I.H., et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat. Med. 9 (2003), 900–906.
21. Saunders, N.R., Habgood, M.D., Mollgard, K., Dziegielewska, K.M., The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system. F1000Res, 5, 2016.
22. Caley, D.W., Maxwell, D.S., Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex. J. Comp. Neurology 138 (1970), 31–47.
23. Obermeier, B., Daneman, R., Ransohoff, R.M., Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 19 (2013), 1584–1596.
24. Daneman, R., Zhou, L., Kebede, A.A., Barres, B.A., Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468 (2010), 526–566.
25. Lindahl, P., Johansson, B.R., Leveen, P., Betsholtz, C., Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277 (1997), 242–245.
26. Hellström, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H., et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol., 153, 2001, 543.
27. O'Kane, R.L., Martinez-Lopez, I., DeJoseph, M.R., Vina, J.R., Hawkins, R.A., Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J. Biol. Chem. 274 (1999), 31891–31895.
28. Pitkin, R.M., Reynolds, W.A., Stegink, L.D., Filer, L.J., Glutamate Metabolism and Placental Transfer in Pregnancy. Glutamic Acid: Advances in Biochemistry and Physiology. 1979, Raven Press, New York, 400 xiv.
29. Ek, C.J., Wong, A., Liddelow, S.A., Johansson, P.A., Dziegielewska, K.M., Saunders, N.R., Efflux mechanisms at the developing brain barriers: ABC-transporters in te fetal and postnatal rat. Toxicol. Lett. 197 (2010), 51–59.
30. Strazielle, N., Ghersi-Egea, J.F., Efflux transporters in blood-brain interfaces of the developing brain. Front. Neurosci., 9, 2015.
31. Mori, S., Takanaga, H., Ohtsuki, S., Deguchi, T., Kang, Y.S., Hosoya, K., et al. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J. Cereb. Blood Flow. Metab. 23 (2003), 432–440.
32. Soares, R.V., Do, T.M., Mabondzo, A., Pons, G., Chhun, S., Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain. Fundam. Clin. Pharmacol. 30 (2016), 107–116.
33. Daneman, R., Zhou, L., Agalliu, D., Cahoy, J.D., Kaushal, A., Barres, B.A., The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE, 5, 2010, e13741.
34. Harati, R., Benech, H., Villegier, A.S., Mabondzo, A., P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signaling. Mol. Pharm. 10 (2013), 1566–1580.
35. Gao, B., Stieger, B., Noe, B., Fritschy, J.M., Meier, P.J., Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J. Histochem Cytochem 47 (1999), 1255–1264.
36. Ohtsuki, S., Takizawa, T., Takanaga, H., Hori, S., Hosoya, K.-i., Terasaki, T., Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells. J. Neurochem. 90 (2004), 743–749.
37. Gao, B., Hagenbuch, B., Kullak-Ublick, G.A., Benke, D., Aquzzi, A., Meier, P.J., Organic anion-transporting polypeptides mediate transport of opiod peptides across blood-brain barrier. J. Pharmacol. Exp. Ther. 294 (2000), 73–79.
38. Wang, C., Li, H., Luo, C., Li, Y., Zhang, Y., Yun, D., et al. The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: implications in the individualized transplacental digoxin treatment for fetal heart failure. Placenta 36 (2015), 1138–1147.
39. Soo, P.S., Hiscock, J., Botting, K.J., Roberts, C.T., Davey, A.K., Morrison, J.L., Maternal undernutrition reduces P-glycoprotein in Guinea pig placenta and developing brain in late gestation. Reprod. Toxicol. 33 (2012), 374–381.
40. Schumacher, U., Mollgard, K., The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem Cell Biol. 108 (1997), 179–182.
41. Beaulieu, E., Demeule, M., Ghitescu, L., Beliveau, R., P-glycoprotein in strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem. J. 326 (1997), 539–544.
42. Daood, M., Tsai, C., Ahdab-Barmada, M., Watchko, J.F., ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 38 (2008), 211–218.
43. Tsai, C.E., Daood, M.J., Lane, R.H., Hansen, T.W.R., Gruetzmacher, E.M., Watchko, J.F., P-glycoprotein expression in mouse brain increases with maturation. Biol. Neonate 81 (2002), 58–64.
44. Ek, C.J., Wong, A., Liddelow, S.A., Johansson, P.A., Dziegielewska, K.M., Saunders, N.R., Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol. Lett. 197 (2010), 51–59.
45. Lam, J., Baello, S., Iqbal, M., Kelly, L.E., Shannon, P.T., Chitayat, D., et al. The ontogeny of P-glucoprotein in the developing human blood-brain barrier: implication for opiod toxicity in neonates. Pediatr. Res. 78 (2015), 417–421.
46. Iqbal, M., Gibb, W., Matthews, S.G., Corticosteroid regulation of P-glycoprotein in the developing blood-brain barrier. Endocrinology 152 (2011), 1067–1079.
47. Petropoulos, S., Gibb, W., Matthews, S.G., Effect of glucocorticoids on regulation of placental multidrug resistance phosphoglycoprotein (P-gp) in the mouse. Placenta 31 (2010), 803–810.
48. Fowden, A.L., Li, J., Forhead, A.J., Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance?. Proc. Nutr. Soc. 57 (1998), 113–122.
49. Coles, L.D., Lee, I.J., Hassan, H.E., Eddington, N.D., Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. J. Pharm. Sci. 98 (2009), 2832–2846.
50. Iqbal, M., Audette, M.C., Petropoulos, S., Gibb, W., Matthews, S.G., Placental drug transporters and their role in fetal protection. Placenta 33 (2012), 137–142.
51. Iqbal, M., Baello, S., Javam, M., Audette, M.C., Gibb, W., Matthews, S.G., Regulation of multidrug resistance P-Glycoprotein in the developing blood-brain barrier: interplay between glucocorticoids and cytokines. J. Neuroendocrinol., 28, 2016, 12360.
52. Qosa, H., Miller, D.S., Pasinelli, P., Trotti, D., Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. Brain Res. 1628 (2015), 298–316.
53. Zhou, S.F., Wang, L.L., Di, Y.M., Xue, C.C., Duan, W., Li, C.G., et al. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr. Med. Chem. 15 (2008), 1981–2039.
54. Miller, D.S., Nobmann, S.N., Gutmann, H., Toeroek, M., Drewe, J., Fricker, G., Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol. Pharmacol. 58 (2000), 1357–1367.
55. Zhang, Y., Schuetz, J.D., Elmguist, W.F., Miller, D.W., Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J. Pharmacol. Exp. Ther. 311 (2004), 449–455.
56. Robey, R.W., To, K.K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., et al. ABCG2: a perspective. Adv. Drug Deliv. Rev. 61 (2009), 3–13.
57. Tachikawa, M., Watanabe, M., Hori, S., Fukaya, M., Ohtsuki, S., Asashima, T., et al. Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J. Neurochem. 95 (2005), 294–304.
58. Orford, M., Mean, R., Lapathitis, G., Genethliou, N., Panayiotou, E., Panayi, H., et al. Generation of an ABCG2 (GFPn-puro) transgenic line–a tool to study ABCG2 expression in mice. Biochem. Biophys. Res. Commun. 384 (2009), 199–203.
59. Miller, D.S., Bauer, B., Hartz, A.M., Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol. Rev. 60 (2008), 196–209.
60. Daw, J.R., Hanley, G.E., Greyson, D.L., Morgan, S.G., Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemoil Drug Saf. 20 (2011), 895–902.
61. Garriguet, D., Medication use among pregnant women. Health Rep. 17 (2006), 9–18.
62. Lacroix, I., Hurault, C., Sarramon, M.F., Guitard, C., Berrebi, A., Grau, M., et al. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur. J. Clin. Pharmacol. 65 (2009), 839–846.
63. Bhuiyan, M., Petropoulos, S., Gibb, W., Matthews, S.G., Sertraline alters multidrug resistance phosphoglycoprotein activity in the mouse placenta and fetal blood-brain barrier. Reprod. Sci. 19 (2012), 407–415.
64. Substance Abuse and Mental Health Administration, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, Office of Applied Studies. 2011, Abuse and Mental Health Services Administration, Rockville, MD.
65. Patrick, S.W., Schumacher, R.E., Benneyworth, B.D., Neonatal abstinence syndrome and associated health care expenditures. JAMA 307 (2012), 1934–1940.
66. Oberdick, J., Ling, Y., Phelps, M.A., Yudovich, M.S., Schilling, K., Sadee, W., Preferential delivery of an opiod antagonist to the fetal brain in pregnant mice. J. Pharmacol. Exp. Ther. 358 (2016), 22–30.
67. Saunders, N.R., Liddelow, S.A., Dziegielewska, K.M., Barrier mechanisms in the developing brain. Front. Pharmacol., 3, 2012, 46.
68. Lopalco, A., Ali, H., Denora, N., Rytting, E., Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast. Int. J. Nanomedicine 10 (2015), 1985–1996.
69. Barzago, M.M., Bortolotti, A., Stellari, F.F., Diomede, L., Algeri, M., Efrati, S., et al. Placental transfer of valproic acid after liposome encapsulation during in vitro human placenta. J. Pharmacol. Exp. Ther. 277 (1996), 79–86.
70. Gerard, E.E., Meador, K.J., An update on maternal use of antiepileptic medications in pregnancy and neurodevelopment outcomes. J. Pediatr. Genet. 4 (2015), 94–110.
71. Stolp, H., Liddelow, S.A., Sa-Pereira, I., Dziegielewska, K.M., Saunders, N.R., Immune responses at brain barriers and implications for brain development and neurological function in later life. Front. Integr. Neurosci., 7, 2013.
72. Shawahna, R., Uchida, Y., Declèves, X., Ohtsuki, S., Yousif, S., Dauchy, S., et al. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol. Pharm. 8 (2011), 1332–1341.
73. Syme, M.R., Paxton, J.W., Keelan, J.A., Drug transfer and metabolism by the human placenta. Clin. Pharmacokinet. 43 (2004), 487–514.
74. Agúndez, J.A.G., Jiménez-Jiménez, F.J., Alonso-Navarro, H., García-Martin, E., Drug and xenobiotic biotransformation in the blood-brain barrier: a neglected issue. Front. Cell Neurosci., 8, 2014.